general – Dupuytren Solutions

general

Insights into chondrocyte populations in cartilaginous tissues at the single-cell level

Insights into chondrocyte populations in cartilaginous tissues at the single-cell level

Conventional Medicine

8 months ago

0

0

Effect of nanoparticle-mediated delivery of SFRP4 siRNA for treating Dupuytren disease

Effect of nanoparticle-mediated delivery of SFRP4 siRNA for treating Dupuytren disease

Conventional Medicine

8 months ago

0

0

CAR T cell therapy for children with rheumatic disease: the time is now

CAR T cell therapy for children with rheumatic disease: the time is now

Conventional Medicine

8 months ago

0

0

Ethnic differences in prevalence of Dupuytren disease can partly be explained by known genetic risk variants

Ethnic differences in prevalence of Dupuytren disease can partly be explained by known genetic risk variants

Conventional Medicine

8 months ago

0

0

The prevalence of Dupuytren’s disease in patients with diabetes mellitus

The prevalence of Dupuytren’s disease in patients with diabetes mellitus

Conventional Medicine

8 months ago

0

0

C-X-C domain ligand 14-mediated stromal cell–macrophage interaction as a therapeutic target for hand dermal fibrosis

C-X-C domain ligand 14-mediated stromal cell–macrophage interaction as a therapeutic target for hand dermal fibrosis

Conventional Medicine

8 months ago

0

0

Advances in the treatment of ANCA-associated vasculitis

Advances in the treatment of ANCA-associated vasculitis

Conventional Medicine

8 months ago

0

0

2023 International Rome consensus for the nomenclature of Sjögren disease

2023 International Rome consensus for the nomenclature of Sjögren disease

Conventional Medicine

8 months ago

0

0

Granzyme K+ CD8 T cells slow tauopathy progression by targeting microglia

Granzyme K+ CD8 T cells slow tauopathy progression by targeting microglia

Autoimmune

8 months ago

0

0